Pancreatic Cancer Research

ResearcherNanjing Medical UniversityActive in the last 2 years

Fangzhou Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9782-8212; OpenAlex author ID A5100683479. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. Transcription factor DDIT3 is a potential driver in pancreatic cancer. Co-author DOI 10.14715/cmb/2024.70.7.21↗
  2. Transcription factor p8 regulates autophagy in response to disulfiram via PI3K/mTOR/p70S6K signaling pathway in pancreatic cancer cells. Co-author DOI 10.1007/s13577-022-00731-3↗
  3. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. Last author PMID 31128031↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao Zhang · 2 shared papers, 2022–2024 · strength 0.40
  2. Guoyuan Ju · 1 shared paper, 2024 · strength 0.24
  3. Zhangyu Yao · 1 shared paper, 2022 · strength 0.16
  4. Baoyu Li · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.